IOVA Iovance Biotherapeutics Inc

$2.21

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

Website: https://www.iovance.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1425205
Address
999 SKYWAY ROAD, SUITE 150, SAN CARLOS, CA, US
Valuation
Market Cap
$1.00B
P/E Ratio
nan
PEG Ratio
0.00
Price to Book
1.41
Performance
EPS
$-1.28
Dividend Yield
—
Profit Margin
-226.80%
ROE
-57.50%
Technicals
50D MA
$4.10
200D MA
$7.71
52W High
$14.23
52W Low
$2.70
Fundamentals
Shares Outstanding
328M
Target Price
$19.18
Beta
1.04

IOVA EPS Estimates vs Actual

● Estimated
● Actual

IOVA News & Sentiment

Sep 19, 2025 • GlobeNewswire NEUTRAL
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 ( c ) ( 4 )
SAN CARLOS, Calif., Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. ( NASDAQ: IOVA ) ( "Iovance" or the "Company" ) , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( "TIL" ) therapies for patients with ...
Sep 19, 2025 • Benzinga NEUTRAL
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - Iovance Biotherapeutics ( NASDAQ:IOVA )
SAN CARLOS, Calif., Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc.
Sep 19, 2025 • Motley Fool SOMEWHAT-BULLISH
Can This Beaten-Down Stock Bounce Back?
This biotech company is innovative, but the market demands more than that.
Aug 29, 2025 • GlobeNewswire NEUTRAL
Iovance Biotherapeutics to Present at Upcoming Conferences
SAN CARLOS, Calif., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. ( NASDAQ: IOVA ) , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( TIL ) therapies for patients with cancer, today announced that ...
Aug 29, 2025 • Business Insider NEUTRAL
Iovance Biotherapeutics to Present at Upcoming Conferences
SAN CARLOS, Calif., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. ( NASDAQ: IOVA ) , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( TIL ) therapies for patients with cancer, today announced that ...
Aug 29, 2025 • Benzinga NEUTRAL
Iovance Biotherapeutics to Present at Upcoming Conferences - Iovance Biotherapeutics ( NASDAQ:IOVA )
SAN CARLOS, Calif., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. IOVA, a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( TIL ) therapies for patients with cancer, today announced that senior leadership ...
Sentiment Snapshot

Average Sentiment Score:

0.065
50 articles with scored sentiment

Overall Sentiment:

Neutral

IOVA Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $-0.26
  • Estimate: $-0.27
  • Whisper: —
  • Surprise %: 2.8%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $-0.28
  • Estimate: $-0.30
  • Whisper: —
  • Surprise %: 6.7%
Aug 08, 2024
Jun 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.35
  • Whisper: —
  • Surprise %: 2.9%
May 09, 2024
Mar 31, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.42
  • Whisper: —
  • Surprise %: 0.0%
Feb 28, 2024
Dec 31, 2023 (Post market)
-0.02 Surprise
  • Reported EPS: $-0.45
  • Estimate: $-0.43
  • Whisper: —
  • Surprise %: -4.7%
Nov 07, 2023
Sep 30, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $-0.46
  • Estimate: $-0.45
  • Whisper: —
  • Surprise %: -2.2%
Aug 08, 2023
Jun 30, 2023 (Post market)
0.33 Surprise
  • Reported EPS: $-0.47
  • Estimate: $-0.80
  • Whisper: —
  • Surprise %: 41.2%
May 09, 2023
Mar 31, 2023 (Post market)
0.24 Surprise
  • Reported EPS: $-0.50
  • Estimate: $-0.74
  • Whisper: —
  • Surprise %: 32.4%
Feb 28, 2023
Dec 31, 2022 (Post market)
0.0 Surprise
  • Reported EPS: $-0.64
  • Estimate: $-0.64
  • Whisper: —
  • Surprise %: 0.0%

Financials